Shares Outstanding for Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's latest reported diluted shares outstanding is 580.70M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingShares OutstandingSwitch metric
Latest period
580.70M
YoY change
-2.3%
5Y CAGR
-1.5%
Peak year (2006)
766.80M
Latest annual
585.80M
Shares Outstanding history chart for Edwards Lifesciences (EW) from 1999 to 2025
Shares Outstanding history table for Edwards Lifesciences (EW) from 1999 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 585.80M | -2.3% | ||
| 2024 | 599.30M | -1.7% | ||
| 2023 | 609.40M | -2.4% | ||
| 2022 | 624.20M | -1.1% | ||
| 2021 | 631.20M | -0.1% | ||
| 2020 | 631.90M | -0.7% | ||
| 2019 | 636.60M | -0.7% | ||
| 2018 | 640.80M | -1.1% | ||
| 2017 | 647.70M | -0.9% | ||
| 2016 | 653.40M | -1.1% | ||
| 2015 | 660.90M | +1.5% | ||
| 2014 | 651.00M | -4.7% | ||
| 2013 | 682.80M | -3.8% | ||
| 2012 | 709.80M | -0.9% | ||
| 2011 | 716.40M | +0.2% | ||
| 2010 | 715.20M | +1.5% | ||
| 2009 | 704.40M | -1.5% | ||
| 2008 | 715.20M | -4.9% | ||
| 2007 | 752.40M | -1.9% | ||
| 2006 | 766.80M | +2.6% | ||
| 2005 | 747.60M | +0.5% | ||
| 2004 | 744.00M | +1.5% | ||
| 2003 | 733.20M | -0.3% | ||
| 2002 | 735.60M | +4.1% | ||
| 2001 | 706.80M | +1.4% | ||
| 2000 | 697.07M | 0.0% | ||
| 1999 | 697.07M | — |
Shares Outstanding values are taken from Edwards Lifesciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Edwards Lifesciences (EW) diluted shares outstanding is 585.80M – edged down 2.3% year-over-year.
Edwards Lifesciences diluted shares outstanding has contracted on net over the period, with a -1.5% compound annual growth rate over 2020–2025 (5 years).
Edwards Lifesciences diluted shares outstanding peaked at 766.80M in 2006; the latest annual figure is 585.80M in 2025 (23.6% below peak).
766.80M stands as the all-time-high annual diluted shares outstanding, posted in 2006, against a low of 585.80M during 2025.
Edwards Lifesciences (EW) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of 1.34B.
Edwards Lifesciences Shares Outstanding by Year
Edwards Lifesciences Shares Outstanding 2025: 585.80M
Edwards Lifesciences diluted shares outstanding in 2025 was 585.80M, edged down 2.3% below 2024. This figure represents the lowest annual value in the available history.
Edwards Lifesciences Shares Outstanding 2024: 599.30M
Edwards Lifesciences diluted shares outstanding in 2024 was 599.30M, edged down 1.7% below 2023.
Edwards Lifesciences Shares Outstanding 2023: 609.40M
Edwards Lifesciences diluted shares outstanding in 2023 was 609.40M, edged down 2.4% below 2022.
Edwards Lifesciences Shares Outstanding 2022: 624.20M
Edwards Lifesciences diluted shares outstanding in 2022 was 624.20M, edged down 1.1% below 2021.
Edwards Lifesciences Shares Outstanding 2021: 631.20M
Edwards Lifesciences diluted shares outstanding in 2021 was 631.20M.
See more financial history for Edwards Lifesciences (EW).
Sector peers — Shares Outstanding
Companies in the same sector as Edwards Lifesciences, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's diluted shares outstanding?
- Latest reported diluted shares outstanding for Edwards Lifesciences (EW) is 580.70M (period ending March 31, 2026).
How has Edwards Lifesciences diluted shares outstanding changed year-over-year?
- Edwards Lifesciences (EW) diluted shares outstanding changed -2.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences diluted shares outstanding?
- Edwards Lifesciences (EW) diluted shares outstanding compound annual growth rate is -1.5% over the most recent 5 years available.
When did Edwards Lifesciences diluted shares outstanding hit its highest annual value?
- Edwards Lifesciences diluted shares outstanding reached its highest annual value of 766.80M in 2006.
What was Edwards Lifesciences diluted shares outstanding in 2024?
- Edwards Lifesciences (EW) diluted shares outstanding in 2024 was 599.30M.
What was Edwards Lifesciences diluted shares outstanding in 2025?
- Edwards Lifesciences (EW) diluted shares outstanding in 2025 was 585.80M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.